In a landmark move, the Indian Patent Office announced on Monday that it has issued its first compulsory license to a domestic generic drug-maker. The decision effectively ends German pharmaceutical company Bayer AG's monopoly over an anti-cancer drug and authorises the production of a low-cost version for the Indian market.
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/india-grants-first-compulsory-license-generic-drug-producer
[2] http://admin.indiaenvironmentportal.org.in/category/journal/bridges-weekly-trade-news-digest
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/supreme-court
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/patents
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/cancer
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/bayer-pharmaceuticals